Improved anti-serum albumin binding variants

Details for Australian Patent Application No. 2010215481 (hide)

Owner Glaxo Group Limited

Inventors De Angelis, Elena; Enever, Carolyn; Liu, Haiqun; Schon, Oliver

Agent Davies Collison Cave

Pub. Number AU-A-2010215481

PCT Pub. Number WO2010/094722

Priority 61/153,746 19.02.09 US; 61/163,990 27.03.09 US

Filing date 17 February 2010

Wipo publication date 26 August 2010

International Classifications

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C07K 14/56 (2006.01) Peptides having more than 20 amino acids

C07K 14/575 (2006.01) Peptides having more than 20 amino acids

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

25 August 2011 PCT application entered the National Phase

  PCT publication WO2010/094722 Priority application(s): WO2010/094722

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010215482-Improved anti-serum albumin binding variants

2010215479-Improved anti-TNFR1 polypeptides, antibody variable domains & antagonists